ClinicalTrials.Veeva

Menu

French Registry of Adult Patients With Immune Thrombocytopenia and Autoimmune Hemolytic Anemia (CARMEN)

T

Toulouse University Hospital

Status

Enrolling

Conditions

Immune Thrombocytopenia
Autoimmune Hemolytic Anemia

Treatments

Other: no specific intervention

Study type

Observational

Funder types

Other

Identifiers

NCT02877706
RC31/12/0386

Details and patient eligibility

About

CARMEN is a national, real-world clinical registry of all adult patients with incident diagnosis of Immune thrombocytopenia (ITP) or Autoimmune Hemolytic anemia (AIHA) patients in France. It is aimed at describing ITP and AIHA clinical features, assessing the real-world risk-benefit ratio of treatments and adherence to guidelines for ITP and AIHA management.

Enrollment

1,500 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • adult patients (18+ year-old)
  • newly diagnosed for ITP/AIHA or initiation of FOSFAMATINIB

Exclusion criteria

  • opposition to data collection

Trial contacts and locations

1

Loading...

Central trial contact

Moulis Guillaume, MD PhD; Johanne Germain, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems